FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003313289> ?p ?o ?g. }

• W2003313289 endingPage "147" @default.
• W2003313289 startingPage "138" @default.
• W2003313289 abstract "Abstract The enhancer of zeste homolog 2 (EZH2), a known repressor of gene transcription, has been reported to be associated with biological malignancy in several cancers. The potential oncogenic role of EZH2 and its clinical/prognostic significance, however, in esophageal squamous cell carcinoma (ESCC) are unclear. In this study, the methods of immunohistochemistry and fluorescence in‐situ hybridization were used to examine protein expression and amplification of EZH2 in 98 pretreatment biopsy specimens of ESCC who received definitive chemoradiotherapy (CRT). High expression of EZH2 and amplification of EZH2 was found in 54.1% and 12.0% of ESCCs, respectively. High EZH2 expression was significantly correlated with increased cell proliferation ( p = 0.009), high histopathological grade ( p = 0.002), regional ( p = 0.025) and distant lymph node metastasis ( p < 0.001) and lack of clinical complete response to CRT ( p = 0.028). Univariate analysis revealed that high expression of EZH2 was associated with poor metastasis‐free survival (MFS) ( p = 0.003), poor progression‐free survival (PFS) ( p = 0.001) and poor disease‐specific survival (DSS) ( p < 0.001). In multivariate analysis, high expression of EZH2, together with lack of clinical complete response, were evaluated as significant independent prognostic factors of MFS, PFS and DSS for patients with ESCC. These findings suggest that high expression of EZH2 correlates with tumor aggressiveness and adverse patient outcome in ESCC treated with definitive CRT. Evaluation of EZH2 expressions might be useful for predicting tumor response to CRT and prognosis for patients with ESCC." @default.
• W2003313289 created "2016-06-24" @default.
• W2003313289 creator A5002034641 @default.
• W2003313289 creator A5007878417 @default.
• W2003313289 creator A5017334175 @default.
• W2003313289 creator A5022919658 @default.
• W2003313289 creator A5024680365 @default.
• W2003313289 creator A5035397993 @default.
• W2003313289 creator A5042973046 @default.
• W2003313289 creator A5044216882 @default.
• W2003313289 creator A5049639446 @default.
• W2003313289 creator A5055280421 @default.
• W2003313289 creator A5075846774 @default.
• W2003313289 creator A5081379987 @default.
• W2003313289 date "2010-04-21" @default.
• W2003313289 modified "2023-10-18" @default.
• W2003313289 title "High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy" @default.
• W2003313289 cites W1965477604 @default.
• W2003313289 cites W1980819213 @default.
• W2003313289 cites W1984420724 @default.
• W2003313289 cites W1987822177 @default.
• W2003313289 cites W1996487270 @default.
• W2003313289 cites W2004339419 @default.
• W2003313289 cites W2006096249 @default.
• W2003313289 cites W2008207367 @default.
• W2003313289 cites W2012028536 @default.
• W2003313289 cites W2023356125 @default.
• W2003313289 cites W2034860020 @default.
• W2003313289 cites W2038388992 @default.
• W2003313289 cites W2039948198 @default.
• W2003313289 cites W2047841120 @default.
• W2003313289 cites W2048074675 @default.
• W2003313289 cites W2074649765 @default.
• W2003313289 cites W2075188294 @default.
• W2003313289 cites W2080344286 @default.
• W2003313289 cites W2086145199 @default.
• W2003313289 cites W2097249378 @default.
• W2003313289 cites W2098752185 @default.
• W2003313289 cites W2100543217 @default.
• W2003313289 cites W2103456217 @default.
• W2003313289 cites W2114318954 @default.
• W2003313289 cites W2115209581 @default.
• W2003313289 cites W2118136541 @default.
• W2003313289 cites W2125496315 @default.
• W2003313289 cites W2127684282 @default.
• W2003313289 cites W2140625837 @default.
• W2003313289 cites W2151598146 @default.
• W2003313289 cites W2153424791 @default.
• W2003313289 cites W2159052403 @default.
• W2003313289 cites W2159815377 @default.
• W2003313289 cites W2171439874 @default.
• W2003313289 cites W2184515929 @default.
• W2003313289 cites W2333900189 @default.
• W2003313289 doi "https://doi.org/10.1002/ijc.25031" @default.
• W2003313289 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19904743" @default.
• W2003313289 hasPublicationYear "2010" @default.
• W2003313289 type Work @default.
• W2003313289 sameAs 2003313289 @default.
• W2003313289 citedByCount "75" @default.
• W2003313289 countsByYear W20033132892012 @default.
• W2003313289 countsByYear W20033132892013 @default.
• W2003313289 countsByYear W20033132892014 @default.
• W2003313289 countsByYear W20033132892015 @default.
• W2003313289 countsByYear W20033132892016 @default.
• W2003313289 countsByYear W20033132892017 @default.
• W2003313289 countsByYear W20033132892018 @default.
• W2003313289 countsByYear W20033132892019 @default.
• W2003313289 countsByYear W20033132892020 @default.
• W2003313289 countsByYear W20033132892021 @default.
• W2003313289 countsByYear W20033132892022 @default.
• W2003313289 countsByYear W20033132892023 @default.
• W2003313289 crossrefType "journal-article" @default.
• W2003313289 hasAuthorship W2003313289A5002034641 @default.
• W2003313289 hasAuthorship W2003313289A5007878417 @default.
• W2003313289 hasAuthorship W2003313289A5017334175 @default.
• W2003313289 hasAuthorship W2003313289A5022919658 @default.
• W2003313289 hasAuthorship W2003313289A5024680365 @default.
• W2003313289 hasAuthorship W2003313289A5035397993 @default.
• W2003313289 hasAuthorship W2003313289A5042973046 @default.
• W2003313289 hasAuthorship W2003313289A5044216882 @default.
• W2003313289 hasAuthorship W2003313289A5049639446 @default.
• W2003313289 hasAuthorship W2003313289A5055280421 @default.
• W2003313289 hasAuthorship W2003313289A5075846774 @default.
• W2003313289 hasAuthorship W2003313289A5081379987 @default.
• W2003313289 hasBestOaLocation W20033132891 @default.
• W2003313289 hasConcept C104317684 @default.
• W2003313289 hasConcept C126322002 @default.
• W2003313289 hasConcept C142724271 @default.
• W2003313289 hasConcept C143998085 @default.
• W2003313289 hasConcept C144301174 @default.
• W2003313289 hasConcept C204232928 @default.
• W2003313289 hasConcept C2775934546 @default.
• W2003313289 hasConcept C2778424827 @default.
• W2003313289 hasConcept C2779399171 @default.
• W2003313289 hasConcept C33288867 @default.
• W2003313289 hasConcept C38180746 @default.
• W2003313289 hasConcept C50171091 @default.
• W2003313289 hasConcept C502942594 @default.

• next